We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gremlin 1 Expression Distinguishes Stem Cells Able to Regenerate Bones and Cartilage in Adult Mice

By LabMedica International staff writers
Posted on 26 Jan 2015
A newly identified type of stem cell in the bone marrow of adult mice was found to be capable of regenerating both bone and cartilage.

Investigators at Columbia University (New York, NY, USA) reported in the January 15, 2015, online edition of the journal Cell that expression of the bone morphogenetic protein (BMP) antagonist gremlin 1 defined a population of osteochondroreticular (OCR) stem cells in the bone marrow. More...


BMPs are considered to constitute a group of pivotal morphogenetic signals, orchestrating tissue architecture throughout the body. Deletion of gremlin 1 in mice caused increased bone formation and increased trabecular bone volume, whereas overexpression caused inhibition of bone formation and osteopenia.

The investigators found that OCR stem cells self-renewed and generated osteoblasts, chondrocytes, and reticular marrow stromal cells, but not adipocytes. OCR stem cells were concentrated within the metaphysis of long bones not in the perisinusoidal space and were needed for bone development, bone remodeling, and fracture repair. Gremlin 1 expression also identified intestinal reticular stem cells (iRSCs) that are cells of origin for the periepithelial intestinal mesenchymal sheath. Thus, gremlin 1 expression identified distinct connective tissue stem cells in both the bone (OCR stem cells) and the intestine (iRSCs).

"Our findings raise the possibility that drugs or other therapies can be developed to stimulate the production of OCR stem cells and improve the body's ability to repair bone injury—a process that declines significantly in old age," said senior author Dr. Timothy C. Wang, professor of medicine at Columbia University.

Related Links:

Columbia University



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.